Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]

（文章来源：证券日报） 证券日报网讯 1月22日，捷昌驱动发布公告称，公司预计2025年年度实现归属于上市公司股东的净利润 39，476.74万元至43，706.39万元，与上年同期相比，将增加11，279.07万元至15，508.72万元，同比增 长40.00%至55.00%。 ...

Group 1 - Huakang Clean announced it is the first candidate for the bid of the Wuhan First Hospital expansion project with a bid amount of 54.88 million yuan and a construction period of 120 days [1] - Hualing Steel's subsidiary plans to invest 449.88 million yuan in a major overhaul project for its coking plant, aiming to address aging issues and restore production capacity over a 19-month construction period [2] - Yinjia Technology expects a net loss of 140 million to 110 million yuan for 2025, compared to a loss of 129 million yuan in the previous year [3] Group 2 - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan for 2025, recovering from a loss of 58.52 million yuan in the previous year [4] - Shiyi Da anticipates a net profit increase of 31 million to 46 million yuan for 2025, turning around from a loss of 23.41 million yuan last year [5] - Lijun Co. expects a net profit of 48 million to 66 million yuan for 2025, representing a decline of 45.05% to 60.03% compared to the previous year [7] Group 3 - Xindian Pharmaceutical plans to repurchase shares worth 25 million to 50 million yuan for employee stock ownership plans or equity incentives, with a maximum repurchase price of 42 yuan per share [6] - Jingchen Co. has set the initial transfer price for its shares at 82.85 yuan per share, with a total of 13.1 million shares to be transferred to 28 institutional investors [8] - Zejing Pharmaceutical received approval for clinical trials of its innovative cancer immunotherapy drug ZG005 in combination with platinum-based chemotherapy for advanced nasopharyngeal and esophageal squamous cell carcinoma [9] Group 4 - Xingqi Eye Medicine expects a net profit of 662 million to 749 million yuan for 2025, marking a growth of 95.82% to 121.56% compared to the previous year [10] - Liancheng Precision anticipates a net loss of 12 million to 17 million yuan for 2025, reducing its loss from 37.96 million yuan in the previous year [11] - Beidou Star expects a net loss of 230 million to 290 million yuan for 2025, improving from a loss of 350 million yuan last year [13] Group 5 - Qing Shan Paper's affiliate won a bid for a wastewater treatment project worth 51.9 million yuan [15] - Yiling Pharmaceutical forecasts a net profit of 1.2 billion to 1.3 billion yuan for 2025, recovering from a loss of 725 million yuan in the previous year [16] - Huahai Pharmaceutical received a drug registration certificate for its product used in treating depression and obsessive-compulsive disorder [23] Group 6 - Nanjing Panda expects a net profit of 10 million to 15 million yuan for 2025, turning around from a loss of 189 million yuan last year [40] - Rui Sheng Intelligent anticipates a net profit of 33.92 million to 38.40 million yuan for 2025, representing a growth of 112% to 140% compared to the previous year [41] - Jiechang Drive expects a net profit of 395 million to 437 million yuan for 2025, with a growth of 40% to 55% compared to the previous year [43]

捷昌驱动（603583）(603583.SH)发布2025年年度业绩预增预告，预计2025年年度实现归属于上市公司 股东的净利润3.95亿元至4.37亿元，与上年同期相比，将增加11,279.07万元至15,508.72万元，同比增长 40.00%至55.00%。 报告期内，公司归属于上市公司股东的净利润及归属于上市公司股东的扣除非经常性损益的净利润较上 年同期实现增长。主要原因有两方面：一是本报告期内公司坚定聚焦主业发展，深化内部精益化管理， 通过提升组织效能等系列举措，持续优化运营效率，有效驱动经营业绩稳步提升;二是上年同期公司计 提商誉减值。综上，公司本期业绩实现稳步增长。 ...

（记者 曾健辉） 每经AI快讯，捷昌驱动1月22日晚间发布业绩预告，预计2025年年度实现归属于上市公司股东的净利润 约3.95亿元~4.37亿元，与上年同期相比，将增加约1.13亿元~1.55亿元，同比增长40%~55%。业绩变动 主要原因是，本报告期内，公司归属于上市公司股东的净利润及归属于上市公司股东的扣除非经常性损 益的净利润较上年同期实现增长。一是本报告期内公司坚定聚焦主业发展，深化内部精益化管理，通过 提升组织效能等系列举措，持续优化运营效率，有效驱动经营业绩稳步提升；二是上年同期公司计提商 誉减值。综上，公司本期业绩实现稳步增长。 每经头条（nbdtoutiao）——特朗普强要格陵兰岛，丹麦一养老基金率先清仓美债，美国资产全线下 跌！欧洲手握"金融核按钮"，双方会"鱼死网破"吗？专家解读→ ...

浙江捷昌线性驱动科技股份有限公司 证券代码：603583 证券简称：捷昌驱动 公告编号：2026-006 2025 年年度业绩预增预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 经财务部门初步测算，预计 2025 年年度实现归属于上市公司股东的净利润 39,476.74 万元至 43,706.39 万元，与上年同期相比，将增加 11,279.07 万元至 15,508.72 万元，同比增长 40.00%至 55.00%。 预计 2025 年年度实现归属于上市公司股东的扣除非经常性损益的净利润 36,481.50 万元至 40,711.15 万元，与上年同期相比，将增加 12,341.48 万元至 16,571.13 万元，同比增长 51.12%至 68.65%。 （三）本期业绩预告未经注册会计师审计。 二、上年同期经营业绩和财务状况 1 业绩预告具体适用于实现盈利，且净利润与上年同期相比增长 50%以上的情 形。 浙江捷昌线性驱动科技股份有限公司（以下简称"公司"）预计 2025 年年度 实现归属于上市公 ...

本报告期内，公司归属于上市公司股东的净利润及归属于上市公司股东的扣除非经常性损益的净利润较 上年同期实现增长。主要原因有两方面：一是本报告期内公司坚定聚焦主业发展，深化内部精益化管 理，通过提升组织效能等系列举措，持续优化运营效率，有效驱动经营业绩稳步提升；二是上年同期公 司计提商誉减值。综上，公司本期业绩实现稳步增长。 格隆汇1月22日丨捷昌驱动(603583.SH)公布，公司预计2025年年度实现归属于上市公司股东的净利润 3.95亿元至4.37亿元，同比增长40.00%至55.00%。预计2025年年度实现归属于上市公司股东的扣除非经 常性损益的净利润3.65亿元至4.07亿元，同比增长51.12%至68.65%。 ...

捷昌驱动公告称，预计2025年年度归属于上市公司股东的净利润为39,476.74万元至43,706.39万元，同比 增长40.00%至55.00%；扣非净利润为36,481.50万元至40,711.15万元，同比增长51.12%至68.65%。上年 同期净利润为28,197.67万元，扣非净利润为24,140.01万元。业绩增长一是因聚焦主业、深化管理、提升 运营效率；二是上年同期计提商誉减值。预告数据为初步核算，具体以年报为准。 ...

每经AI快讯，1月22日，捷昌驱动（603583）(603583.SH)发布2025年度业绩预告，预计归属于上市公司 股东的净利润为3.95亿元至4.37亿元，比上年同期增长40.00%-55.00%。报告期内，公司聚焦主业发展， 深化精益化管理，提升组织效能，优化运营效率，同时上年同期计提商誉减值，共同推动业绩稳步增 长。 ...

南财智讯1月22日电，捷昌驱动公告，预计2025年全年归属于上市公司股东的净利润为39,476.74万元至 43,706.39万元，同比预增40.00%—55.00%；预计2025年全年归属于上市公司股东的扣除非经常性损益 的净利润为36,481.50万元至40,711.15万元，同比预增51.12%—68.65%；主要变动原因为：本报告期 内，公司归属于上市公司股东的净利润及归属于上市公司股东的扣除非经常性损益的净利润较上年同期 实现增长。主要原因有两方面：一是本报告期内公司坚定聚焦主业发展，深化内部精益化管理，通过提 升组织效能等系列举措，持续优化运营效率，有效驱动经营业绩稳步提升；二是上年同期公司计提商誉 减值。综上，公司本期业绩实现稳步增长。 ...